These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27555601)

  • 1. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting.
    Aloi J; Bode BW; Ullal J; Chidester P; McFarland RS; Bedingfield AE; Mabrey M; Booth R; Mumpower A; Wallia A
    J Diabetes Sci Technol; 2017 Jan; 11(1):12-16. PubMed ID: 27555601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academic Medical Center.
    Rabinovich M; Grahl J; Durr E; Gayed R; Chester K; McFarland R; McLean B
    J Diabetes Sci Technol; 2018 Jan; 12(1):47-52. PubMed ID: 29251064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of "Comparison an Electronic Glycemic Management System Versus Provider Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting".
    Leitgeb S; Mader JK
    J Diabetes Sci Technol; 2017 Jan; 11(1):17-19. PubMed ID: 28264175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System.
    Newsom R; Patty C; Camarena E; Sawyer R; McFarland R; Gray T; Mabrey M
    J Diabetes Sci Technol; 2018 Jan; 12(1):53-59. PubMed ID: 29237289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USE OF A COMPUTER-GUIDED GLUCOSE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC CONTROL AND ADDRESS NATIONAL QUALITY MEASURES: A 7-YEAR, RETROSPECTIVE OBSERVATIONAL STUDY AT A TERTIARY CARE TEACHING HOSPITAL.
    Tanenberg RJ; Hardee S; Rothermel C; Drake AJ
    Endocr Pract; 2017 Mar; 23(3):331-341. PubMed ID: 27967226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.
    Smiley D; Umpierrez GE; Hermayer K; Newton C; Jacobs S; Olson DE; Khan A; Rizzo M; Peng L; Reyes D; Cardona S; Fonseca V
    J Diabetes Complications; 2013; 27(6):637-41. PubMed ID: 23911535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Efficacy and Safety of an eGlycemic Management System in a Community Hospital Setting.
    Bouldin MG; Hong B; Setji T; Greenlee J; Cooper A; Thompson J; Capes K
    J Diabetes Sci Technol; 2021 Mar; 15(2):236-241. PubMed ID: 33322926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms.
    Newton CA; Smiley D; Bode BW; Kitabchi AE; Davidson PC; Jacobs S; Steed RD; Stentz F; Peng L; Mulligan P; Freire AX; Temponi A; Umpierrez GE
    J Hosp Med; 2010 Oct; 5(8):432-7. PubMed ID: 20945468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving IV insulin administration in a community hospital.
    Magee MC
    J Vis Exp; 2012 Jun; (64):e3705. PubMed ID: 22710978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery.
    Magaji V; Nayak S; Donihi AC; Willard L; Jampana S; Nivedita P; Eder R; Johnston J; Korytkowski MT
    Diabetes Technol Ther; 2012 Nov; 14(11):1013-7. PubMed ID: 23046399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions.
    Braithwaite SS; Edkins R; Macgregor KL; Sredzienski ES; Houston M; Zarzaur B; Rich PB; Benedetto B; Rutherford EJ
    Diabetes Technol Ther; 2006 Aug; 8(4):476-88. PubMed ID: 16939372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved safety with intravenous insulin therapy for critically ill patients with renal failure.
    Dickerson RN; Lynch AM; Maish GO; Croce MA; Minard G; Brown RO
    Nutrition; 2014 May; 30(5):557-62. PubMed ID: 24296035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.
    Fayfman M; Galindo RJ; Rubin DJ; Mize DL; Anzola I; Urrutia MA; Ramos C; Pasquel FJ; Haw JS; Vellanki P; Wang H; Albury BS; Weaver R; Cardona S; Umpierrez GE
    Diabetes Care; 2019 Mar; 42(3):450-456. PubMed ID: 30679302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.
    Bellido V; Suarez L; Rodriguez MG; Sanchez C; Dieguez M; Riestra M; Casal F; Delgado E; Menendez E; Umpierrez GE
    Diabetes Care; 2015 Dec; 38(12):2211-6. PubMed ID: 26459273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin.
    Marvin MR; Inzucchi SE; Besterman BJ
    Diabetes Technol Ther; 2013 Mar; 15(3):246-52. PubMed ID: 23289409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.
    Gómez AM; Imitola Madero A; Henao Carrillo DC; Rondón M; Muñoz OM; Robledo MA; Rebolledo M; García Jaramillo M; León Vargas F; Umpierrez G
    J Diabetes Sci Technol; 2020 Mar; 14(2):233-239. PubMed ID: 30678495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased rates of hypoglycemia following implementation of a comprehensive computerized insulin order set and titration algorithm in the inpatient setting.
    Sinha Gregory N; Seley JJ; Gerber LM; Tang C; Brillon D
    Hosp Pract (1995); 2016 Dec; 44(5):260-265. PubMed ID: 27805455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.